Baron Silver Stevens Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$931K Sell
775
-9
-1% -$9.2K 0.12% 67
2026
Q1
$722K Sell
784
-75
-9% -$76K 0.1% 71
2025
Q4
$924K Sell
859
-146
-15% -$140K 0.13% 63
2025
Q3
$767K Buy
1,005
+78
+8% +$58K 0.11% 68
2025
Q2
$722K Buy
927
+49
+6% +$38.1K 0.12% 69
2025
Q1
$725K Buy
878
+14
+2% +$11.6K 0.13% 62
2024
Q4
$667K Hold
864
0.11% 64
2024
Q3
$765K Buy
864
+80
+10% +$71.9K 0.13% 60
2024
Q2
$710K Sell
784
-58
-7% -$46.4K 0.13% 60
2024
Q1
$655K Sell
842
-33
-4% -$23.5K 0.13% 63
2023
Q4
$510K Sell
875
-137
-14% -$80K 0.11% 64
2023
Q3
$543K Buy
1,012
+29
+3% +$14.9K 0.12% 58
2023
Q2
$461K Buy
983
+61
+7% +$25.6K 0.1% 64
2023
Q1
$316K Buy
922
+43
+5% +$14.5K 0.08% 71
2022
Q4
$321K Buy
+879
New +$312K 0.08% 68
2022
Q3
Sell
-1,037
Closed -$336K 129
2022
Q2
$336K Buy
1,037
+158
+18% +$47.4K 0.09% 72
2022
Q1
$251K Buy
+879
New +$226K 0.06% 85
2021
Q1
Sell
-367
Closed -$62K 278
2020
Q4
$62K Buy
+367
New +$54.8K 0.02% 125

Other funds holding LLY

Baron Silver Stevens Financial Advisors's LLY Position: Q2 2026 in Review

Baron Silver Stevens Financial Advisors reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2026, selling an estimated $9.2K and leaving 775 shares worth $931K. The position accounts for 0.12% of the portfolio, ranked #67.

Baron Silver Stevens Financial Advisors first reported a position in LLY in Q4 2020 and has held it in 18 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Baron Silver Stevens Financial Advisors held 775 shares of Eli Lilly worth $931K as of Q2 2026.
  • Baron Silver Stevens Financial Advisors sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.12% of Baron Silver Stevens Financial Advisors's portfolio in Q2 2026, its #67 holding.
  • Baron Silver Stevens Financial Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 18 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.